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Abstract: Ferulago angulata is a medicinal plant that is traditionally known for its 
 anti-inflammatory and antiulcer properties. The present study was aimed to evaluate its anticancer 
activity and the possible mechanism of action using MCF-7 as an in vitro model. F. angulata leaf 
extracts were prepared using solvents in the order of increasing polarity. As determined by MTT 
assay, F. angulata leaves hexane extract (FALHE) revealed the strongest cytotoxicity against 
MCF-7 cells with the half maximal inhibitory concentration (IC
50
)
 
value of 5.3±0.82 µg/mL. 
The acute toxicity study of FALHE provided evidence of the safety of the plant extract. Micro-
scopic and flow cytometric analysis using annexin-V probe showed an induction of apoptosis in 
MCF-7 by FALHE. Treatment of MCF-7 cells with FALHE encouraged the intrinsic pathway 
of apoptosis, with cell death transducing signals that reduced the mitochondrial membrane 
potential with cytochrome c release from mitochondria to cytosol. The released cytochrome c 
triggered the activation of caspase-9. Meanwhile, the overexpression of caspase-8 suggested 
the involvement of an extrinsic pathway in the induced apoptosis at the late stage of treatment. 
Moreover, flow cytometric analysis showed that FALHE treatment significantly arrested 
MCF-7 cells in the G
1
 phase, which was associated with upregulation of p21 and p27 assessed 
by quantitative polymerase chain reaction. Immunofluorescence and the quantitative polymerase 
chain reaction analysis of MCF-7 cells after treatment with FALHE revealed an upregulation of 
Bax and a downregulation of Bcl-2 proteins. These findings proposed that FALHE suppressed 
the proliferation of MCF-7 cells via cell cycle arrest and the induction of apoptosis through 
intrinsic pathway.
Keywords: Ferulago angulata, apoptosis, cancer, MCF-7, cell cycle, p21/p27
Introduction 
Cancer is a debilitating disease that has caused a markedly high death rate in all 
 generations. Despite noteworthy progress in reducing cancer incidence and the devel-
opments in chemotherapeutic strategies, it is still a major public health problem in 
many parts of the world.1 The available chemotherapeutic agents only provide minimal 
survival benefits in advanced-stage cancer due to various factors, namely toxicity, 
side effects, and drug resistance.2,3 The main modes of therapy used for the treatment 
of this disease are surgery and chemotherapy, with varying degrees of failure due 
to high resistance to chemotherapy.4 Treatment responses are especially gloomy for 
hormone-independent cancers. Hence, research into new therapeutic agents for these 
cancers is clearly warranted.5,6
Natural products have been used for the treatment of different ailments and diseases 
for thousands of years.7,8 Thus, because of the similarity between body composition 
and plant ingredients and the long history of folk medicine from traditional plants, 
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there is a rising interest in plant-derived medicines.9 The 
World Health Organization estimates that roughly 80% of the 
world’s inhabitants rely on folk medicine for their primary 
health care.10 Natural products’ contribution to cancer therapy 
is very evident considering the fact that they were involved 
in the development of approximately 75% of all novel anti-
cancer agents from 1981–2012.11,12 Plant products induce cell 
death by a variety of mechanisms. The most prevalent mecha-
nisms are programmed cell death (PCD)-type I (apoptosis), 
PCD-type II autophagic cell death, and necrosis.13 
Apoptosis is a mode of self-cannibalism, which involves 
individual cells and does not cause inflammation to the neigh-
boring cells.14,15 Thus, apoptosis, which is characterized by 
a series of biochemical and morphological changes, includ-
ing deoxyribonucleic acid (DNA) fragmentation, nuclear 
condensation, externalization of phosphatidylserine (PS), 
membrane blebbing, and loss of mitochondrial membrane 
potential (MMP), has become a mechanism of interest in drug 
research.16,17 Mitochondria are found to be a crucial factor 
in the regulation of apoptosis.17 A loss in MMP leads to the 
translocation of proapoptotic Bax to mitochondria, which 
results in the release of cytochrome c and the activation 
of caspase cascades.18 In addition, excessive production of 
reactive oxygen species leading to oxidative stress and the 
depletion of the glutathione level has been reported to be a 
trigger to apoptotic signaling.19,20
Ferulago angulata, locally known as chavir, is a member 
of the Apiaceae family, which is mostly indigenous to Iraq, 
Turkey, and western Iran.21 This perennial shrub, with a 
height of ~60–150 cm, is widely used in folk medicine to treat 
digestive pains, hemorrhoids, snake bites, and ulcers.22,23 Pre-
vious studies have demonstrated antibacterial and antifungal 
properties of F. angulata.24 The leaves and flowers of this 
plant showed angiogenesis and migration suppressive effect 
against human umbilical vein endothelial cells via downregu-
lation of vascular endothelial growth factor-A and vascular 
endothelial growth factor receptor-2 mRNA expression.23 
In addition, cytotoxic effect of F. angulata against K562 and 
Jurkat cancer cells suggested that this plant has promising 
anticancer properties.25,26 Hence, this study was to inves-
tigate the anticancer activity of F. angulata leaves on the 
MCF-7 cancer cell line. 
Materials and methods
Plant materials 
F. angulata plants were collected from Shahrekord, 
 Chaharmahal and Bakhtiari province, Iran, in March 2012, 
and a voucher specimen of this plant has been deposited 
at the Herbarium, Biological Institute, Shahrekord Azad 
 University, Iran. The leaves of F. angulata were cut into thin 
slices and dried at 25°C. The dried leaves (1.5 kg) were then 
ground with a mill grinder into coarse powder and were first 
extracted with n-hexane (3,000 mL, three times) in conical 
flasks. The leaves’ residues were then dried and sequentially 
reextracted with dichloromethane and methanol using the 
same method. The resulting filtrates were dried under reduced 
pressure by a rotary evaporator (Büchi Labortechnik GmbH, 
Essen, Germany) at 35°C to produce n-hexane (14 g), dichlo-
romethane (10 g), and methanol (9 g) extracts, respectively. 
The extracts were dissolved in dimethyl sulfoxide (DMSO), 
(Sigma, St Louis, MO, USA) and stored in -20°C until fur-
ther experiments. 
cell culture and cell viability assay
A549 (human lung cancer cells), CCD841 (normal human 
colon epithelial cells), HepG2 (human hepatoma cells), 
HT29 (human colon cancer cells), MCF-7, and MDA-
MB-231 (human breast cancer cells), PC3 (human prostate 
cancer cells), and WRL-68 (human hepatic cells) cell lines 
were purchased from American Type Culture Collection 
(ATCC) (Manassas, VA, USA). The cells were maintained 
in Roswell Park Memorial Institute 1640 or Dulbecco’s 
Modified Eagle’s Medium (Sigma), supplemented with 10% 
fetal bovine serum (PAA Laboratories GmbH, Pasching, 
Austria) and 1% penicillin/streptomycin (PAA; 100 µg/mL) 
in a 37°C incubator with 5% CO
2 
saturation. Negative control 
for all the assays was represented by the untreated medium 
containing vehicle DMSO (0.1%).
Cell viability was determined using MTT assay. In brief, 
cells (5×104 cells/mL) were treated with three extracts at 
different concentrations in 96-well plates and incubated for 
48 hours at 37°C. MTT was added to the wells and incu-
bated for 3 hours. Cell media was replaced by DMSO and 
pipetted to dissolve the formed formazan crystals. Then, 
optical density of the colored solution was quantified at 
570 nm wavelength using a microplate reader (UVM340; 
Asys-Hitech GmbH, Eugendorf, Austria). The potency of cell 
growth inhibition for each of the three extracts was expressed 
as an IC
50 
value. MCF-7 cells treated with F. angulata leaves 
hexane extract (FALHE) revealed the lowest IC
50
 when 
compared to cells treated with the other extracts; therefore, 
we only used FALHE for further studies. The percentage of 
cell viability = (absorbance of treated cells/absorbance of 
untreated cells) ×100%.
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animal experiments and acute  
toxicity assay
This experiment was carried out after approval by the 
 University of Malaya Institutional Ethics Committee (Ethic 
#: FAR/26/07/2013/HK [R]). In addition, 6–8 week old rats 
(150–180 g) were obtained from the Experimental Animal 
House facility, Faculty of Medicine, University of Malaya. 
All animals received care, according to the current guidelines 
for the care of laboratory animals prepared by the National 
Academy of Sciences and published by the National Institutes 
of Health Sciences. Also, 18 female rats were divided into 
three groups and placed in cages that were labeled as: “low 
dose group” (FALHE, 2 g/kg); “high dose group” (FALHE, 
5 g/kg); and “vehicle control group” (Tween-20 10% weight/
volume; 5 mL/kg). Before dosing, the rats were fasted over-
night but allowed access to water. After fasting, each group 
was administered with its respective compound, further 
deprived of food for 3–4 hours, and monitored for 14 days 
for any sign of toxicity and mortality. Histological, hema-
tological, and serum biochemical parameters were assessed 
after sacrificing the animals on the 15th day. 
chemical analysis assay
To determine the chemical constituents of FALHE, we 
 carried out the gas chromatography (GC)–mass spectrometry 
(MS)–time of flight analysis (TOF) analysis, as previously 
described.27 The analysis of the FALHE was performed using 
an Agilent and LECO GC-MS, with the following features: 
RESTEK, Rxi-5MS capilary column (30 minutes; 0.25 µm 
film thickness) and a mass spectrometer Pegasus HT High 
Throughput TOFMS. The carrier gas was helium at a flow rate 
of 1 mL/minute. Column temperature was initially 40°C for 
5 minutes, then gradually increased to 160°C at 4°C/minute, 
and finally increased to 280°C at 5°C/minute and held for 
10 minutes. For GC–MS detection, an electron ionization 
system was used with ionization energy of 70 eV. The fraction 
was diluted 1:100 (volume/volume) with ethyl acetate, and 
1.0 µL of the diluted sample was injected automatically in 
splitless mode. The injector temperature was set at 250°C. The 
detected compounds were identified from their mass spectra 
by comparison of the retention times of peaks with interpreta-
tion of MS fragmentation patterns from data library.
Annexin-V-fluorescein isothiocyanate 
(FiTc) assay
Annexin-V, as a Ca2+-dependent phospholipid-binding 
 protein, detects the plasma membrane alterations, such as the 
PS externalization during the early stages of apoptosis.28 The 
effect of FALHE on the induction of early apoptosis was 
analyzed in MCF-7 cells using the annexin-V probe. The 
MCF-7 cells (5×104 cells/mL) at the exponential phase of 
growth were seeded into a chamber slide plate. After 48 hours 
of FALHE treatment at IC
50 
doses, they were washed with 
phosphate buffered saline (PBS) and stained with fluorescein- 
labeled annexin-V containing a binding buffer. The 
MCF-7 cells were observed under fluorescent microscopy, 
Olympus BX51 (Olympus Corporation, Tokyo, Japan).
To confirm PS translocation suggesting an induction of 
apoptosis by FALHE observed in microscopic investiga-
tion, we carried out the flow cytometric analysis using the 
BD Pharmingen Annexin V-FITC Apoptosis Detection Kit 
(APOAlert® Annexin V; Clontech, Mountain View, CA, 
USA). In brief, MCF-7 cells (1×105 cells/mL) at the exponen-
tial phase of growth were exposed to FALHE at IC
50
 concen-
tration for 24, 47, and 72 hours. After centrifuging the cells 
and removing the media, the MCF-7 cells were washed twice 
with PBS and resuspended in the annexin-V binding buffer. 
The cells were then stained with annexin-V-FITC and pro-
pidium iodide (PI), according to the manufacturer’s instruc-
tions. The flow cytometric analysis was performed using BD 
FACSCanto II flow cytometer (BD Biosciences, San Jose, CA, 
USA) followed by quadrant statistics analysis for the detection 
of early and late apoptotic cells and necrotic cells.
cell cycle analysis
Cell cycle analysis was carried out using a flow cytometer 
as previously described.29 In brief, the MCF-7 cells 
(5×104 cells/mL) at the exponential phase of growth were 
treated with FALHE for 24, 48, and 72 hours. After incuba-
tion, treated MCF-7 cells were centrifuged and washed with 
PBS twice prior fixing with 95% cold ethanol (700 µL) at 
4°C overnight. After fixing, the cells were washed again 
and resuspended in PBS (500 µL). The fixed MCF-7 cells 
were treated with PI (80 µL; 1 mg/mL) for 45 minutes, and 
the binding ability of PI was restricted to DNA by adding 
the ribonuclease A (20 µL; 10 mg/mL) for degradation of 
RNAs. The DNA content of the cells was analyzed by using 
a BD FACSCanto II flow cytometer (BD Biosciences, San 
Jose, CA, USA) and a ModFit LT software (Verity Software 
House, Inc., Topsham, ME, USA).
caspase analysis
The effect of FALHE on the activation of caspase-8 
and caspase-9 was investigated using a commercial kit 
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(Caspase-Glo 8 assay and Caspase-Glo 9 assay; Promega 
Corporation, Fitchburg, WI, USA), as previously described.6 
In brief, the MCF-7 cells (2×104 cells/well) were plated in 
white-walled 96-well plate and treated with IC
50 
doses of 
FALHE for 3, 6, 12, 24, 48, and 72 hours. After the incuba-
tion time, Caspase-Glo Reagent -8 and -9 (50 µL) was added 
to each well and incubated for 30 minutes in the dark. The 
activation of the caspases was investigated using a lumines-
cence microplate reader (Infinite M200PRO; Tecan Schweiz 
AG, Männedorf, Switzerland). 
Multiple cytotoxicity assay 
Multiple cytotoxicity was determined using the Cellomics 
Multiparameter Cytotoxicity 3 Kit (Cellomics, Pittsburgh, 
PA, USA), as previously described in detail.30 This kit pro-
vides simultaneous measurements of four independent cell 
health parameters in a single cell, ie, changes in nuclear 
intensity, cell membrane permeability, cytochrome c release, 
and MMP. In this experiment, MCF-7 cells were stained 
with the nuclear dye (Hoechst 33342), cell permeability dye 
(FITC), mitochondrial membrane potential dye (Cy5), and 
cytochrome c dye (Cy3). The plates were analyzed using the 
ArrayScan HCS system (Cellomics).
Apoptosis proteome profiler array 
To determine the probable mechanism of action for induced 
apoptosis by FALHE, we examined the proteins involved in 
different pathways of apoptosis using the Proteome Profiler 
Array (RayBio Human Apoptosis Antibody Array Kit, 
RayBiotech, Inc., Norcross, GA, USA), according to 
the manufacturer’s protocol. Briefly, after treatment of 
MCF-7 cells with FALHE at IC
50 
dose for 48 hours, the 
proteins were extracted from each sample, and 300 µg 
of the extracted proteins were incubated with the human 
apoptosis array for 24 hours. The membrane was then used 
to quantify the result via scanning on a Biospectrum AC 
ChemiHR 40 (UVP, Upland, CA, USA). An image analysis 
software (Progenesis SameSpots software v.2.0.2733.19819; 
Nonlinear Dynamics, Newcastle, UK) was used to analyze 
the array image file. 
gene expression analysis of Bax/Bcl-2 
and p21/p27
The gene expression of four proteins, namely Bax, Bcl-2, 
p21, and p27, which demonstrated the highest changes 
in proteome profiler array when compared to the control, 
was investigated by quantitative polymerase chain reac-
tion analysis. After treatment of MCF-7 cells with FALHE 
at an IC
50
 dose for 24, 48, and 72 hours, total RNAs were 
isolated using a Quick-RNA MiniPrep kit (Zymo Research, 
Freiburg, Germany), followed by the synthesization of 
complementary DNAs using a High-Capacity RNA-to-cDNA 
kit (Applied Biosystems, Foster City, CA, USA), according 
to the manufacturer’s instructions. The gene expression was 
measured, based on the relative expression of β-actin as a 
positive reference. Applied Biosystems StepOnePlus sys-
tem (Applied Biosystems), Solaris qPCR Gene Expression 
Master Mix and Solaris Gene Expression (Thermo Fisher 
Scientific, Waltham, MA, USA) Assays were used for the 
gene expression analysis of: Bcl-2, AX-003307-00-0100; 
Bax, AX-003308-00-0100; p21, AX-003471-00-0100; p27, 
AX-003472-00-0100; GAPDH, AX-004253-00-0100; and 
β-actin, AX-003451-00-0100. 
Immunofluorescence analysis  
of Bax/Bcl-2
To determine the changes in the expression of Bax and 
Bcl-2 at the protein level, immunofluorescence analysis was 
carried out using the Cell Reporter™ (Molecular Devices, 
Wokingham, UK).31 The MCF-7 cells (5×103 cells/well) at 
the exponential phase of growth were seeded in 96-well 
plate and treated with FALHE at IC
50
 dose for 24, 48, and 
72 hours. After incubation, the cells were fixed using 4% 
paraformaldehyde at 25°C for 15 minutes. Then, each well 
was supplied with blocking buffer (0.03% Triton X-100/
PBS and normal serum) for 1 hour. After blocking, the 
cells were treated with diluted primary antibody solution 
(1× PBS; BSA/0.3% Triton X-100) and incubated overnight 
at 4°C. Bax and Bcl-2 fluorochrome-conjugated secondary 
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, 
USA) were diluted in PBS and added to each well and 
incubated for 1 hour at room temperature. Cells were treated 
with 4′,6-diamidino-2-phenylindole (DAPI) and examined 
using the Cell Reporter™ cytofluorimetric system. During 
the process, cells were washed twice with PBS after every 
single step. 
statistical analysis
Each assay was carried out three times independently. 
Statistical analysis was performed using the statistical 
package GraphPad Prism Version 5 (GraphPad Software 
Inc., San Diego, USA) and the SPSS-16.0 package (SPSS 
Inc., Chicago, IL, USA, USA). One-way analysis of vari-
ance (Dunnett’s multiple comparison test) was used to 
distinguish the difference among groups. The results are 
presented as the means ± standard error of the mean of three 
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 independent experiments. *P0.05 was considered statisti-
cally significant. 
Results and discussion
cytotoxic effects of Falhe on different 
cancer cells
The cytotoxic effects of three F. angulata extracts on 
 different cancer cells were determined using the MTT assay. 
Dichloromethane and methanol extracts did not show sig-
nificant cytotoxic effect toward cancer cells compared to the 
hexane extract. Meanwhile, the FALHE treatment of cancer 
cells for 48 hours decreased cell proliferation with a wide 
range of suppressive effects (IC
50
 ranged from 5.3±0.82 to 
70.25±7.42 µg/mL), due to the various range of resistance 
shown by cancer cells. As shown in Figure 1A, FALHE 
elicited the strongest cytotoxicity effect on the MCF-7 cells 
with the IC
50
 value of 5.3±0.82 µg/mL at 48 hours. 
In addition, the suppressive effect of FALHE on 
MCF-7 cells was proved to be concentration- and time-
dependent (Figure 1B). In contrast, even the highest concen-
tration of FALHE (50 µg/mL) did not significantly affect the 
proliferation of normal cells (WRL-68 and CCD-841). The 
cell viability implied FALHE’s suppressive effect is selective 
for cancer cells. Following these results, MCF-7 cells and 
FALHE were chosen for subsequent experiments. Findings 
from this study were comparable with a previous study, 
which showed significant cytotoxic effects of F. angulata 
against the Jurkat cell line (IC
50 
8 µg/mL).25 However, 
an investigation on its suppressive effect on Raji (B-cell 
lymphoma), U937 (human leukemic monocyte lymphoma), 
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Figure 1 suppressive effect of Falhe against cancer and normal cells.
Notes: (A) ic50 concentration of Falhe on eight different cell lines after 48 hours of treatment. (B) Falhe suppressed McF-7 cell proliferation in a concentration- and 
time-dependent manner. *P0.05.
Abbreviations: ic50, half maximal inhibitory concentration; Falhe, Ferulago angulata leaves hexane extract. 
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and KG-1A (human acute myelocytic leukemia) cell lines 
showed relatively high IC
50 
values of 96.81, 158.68, and 
128.47 µg/mL, respectively.26
safety of Falhe
The extensive traditional use of plant remedies by natives 
for a long period of time without any report of toxicity or 
adverse side effects can generally provide some evidence 
for the safety of the respective plant.32 However, previous 
studies showed that some chemical constituents or second-
ary metabolites present in traditional medicines have toxic 
or even carcinogenic effects on human body.32–34 Therefore, 
investigation on the safety of plants prior to performing 
any experiment on their biological activity is highly recom-
mended to avoid any undesirable adverse side effects. 
The acute toxicity study of FALHE demonstrated the 
safety of this extract, since during the 14 days period all 
the rats remained alive and did not show any sign of toxic-
ity even at a high dose of 5 g/kg. In addition, histological, 
hematological, and serum biochemical analysis did not show 
any sign of hepatic or renal toxicity in the treatment groups 
(Figure 2; Table S1). 
chemical analysis of Falhe
The chemical composition of FALHE was characterized 
using GC-MS-TOF analysis (Figure 3). The chromatogram 
showed two monoterpenoid phenols as major compounds, 
ie, thymol (3, C
10
H
14
O) and carvacrol (4, C
10
H
14
O) (Table 1). 
Previous studies showed that these two phenolic compounds 
have promising anticancer effects against cancer cell lines. 
Thymol was found to induce apoptosis in HL-60 cells 
through both caspase-dependent and caspase-independent 
pathways.35 The marked antiproliferative effect of carvacrol 
and its mechanism of action toward different cancer cells, 
A
D E F
B C
100 µm
100 µm 100 µm
100 µm 100 µm
100 µm
Figure 2 histological sections of liver and kidney.
Notes: histological (hematoxylin and eosin stain, 20×) of liver (A–C) and kidney (D–F) did not show any abnormality after treatment with (B and E) 2 g/kg and 5 g/kg 
(C and F) of Falhe, compared to the vehicle 10% Tween-20 (A and D).
Abbreviation: Falhe, Ferulago angulata leaves hexane extract. 
Table 1 gc-Ms-TOF analysis showed eleven detected compounds in Falhe
Peak Name of compound Retention time (seconds) Mass (g/mol)
1 Methanesulfonyl acetic acid 284.35 138
2 heptane, 2-methyl 542.5 114
3 Thymol 714.1 150
4 carvacrol 714.8 150
5
6
2(4)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl
2-pentanone,4-hydroxy-4-methyl
1,533.85
3,233.5
180
116
7 4a-methyl-1-methylene-1,2,3,4,4a,9,10,10a-octahydrophenanthrene 3,260.6 197
8 1-ethoxy-7-phenylvinylidene-bicyclo heptane 3,335.7 240
9 6h-dibenzo-pyran 3,474.9 181
10 aromadendrene epoxide 3,550.55 205
11 9-octadecenamide 3,625.3 281
Abbreviations: GC, gas chromatography; MS, mass spectrometry; TOF, time of flight analysis; FALHE, Ferulago angulata leaves hexane extract.
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Figure 3 chemical constituents of Falhe determined by a gas chromatogram analysis.
Note: 3 (Thymol) and 4 (carvacrol) are the major compounds based on their intensity.
Abbreviations: Falhe, Ferulago angulata leaves hexane extract; aic, analytical ion chromatogram.
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B C
Figure 4 Microscopic evaluation of the Ps externalization.
Notes: (A) Untreated cells (control) did not show any sign of Ps translocation as an early marker for apoptosis. after 48 hours of treatment with ic50 concentration of 
Falhe, annexin-V-FiTc binding to Ps residues shown in the light green stain demonstrated the externalization of Ps. The treated cells were shown with (B) 20× and 
(C) 40× magnifications. The white arrows show the PS externalization in treated cells.
Abbreviations: Ps, phosphatidylserine; ic50, half maximal inhibitory concentration; Falhe, Ferulago angulata leaves hexane extract; FITC, fluorescein isothiocyanate.
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including MDA-MB-231,36 HepG-2,37 and A54938 cells, has 
previously been investigated. The suppressive effects of these 
two phenolic compounds on cancer cells are closely corre-
lated with the IC
50
 value of FALHE toward different cancer 
cells. However, a study with a bioassay-guided approach on 
FALHE is further required to certainly determine the major 
bioactive compounds responsible for the observed cytotoxic 
effects, which is ongoing in our laboratory. 
externalization of Ps induced by Falhe
Apoptotic properties of cancer cells are the critical key to most 
of the approaches applied in radiation and chemotherapy. 
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Figure 5 Flow cytometric analysis of apoptosis in McF7 cells.
Notes: (A) shows the untreated McF-7 cells (control) after 72 hours. after treatment with ic50 concentration of Falhe for (B) 24, (C) 48 and (D) 72 hours, flow cytometry 
analysis was carried out on McF7 treated and untreated cells. Meanwhile, (E) representative bar chart showed a significant elevation in the number of apoptotic and necrotic 
cells after 72 hours. *P0.05.
Abbreviation: Falhe, Ferulago angulata leaves hexane extract.
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Thus, it has considerable therapeutic implications.39 Apop-
tosis is characterized by various biochemical changes in 
cells, mainly nuclear condensation, DNA fragmentation, 
PS externalization, MMP changes, membrane blebbing, 
and regulations in caspases’ enzymes. These changes are 
considered as the biomarkers of apoptosis.40
PCD (apoptosis) has two distinct phases, namely, early 
and late apoptosis. A simple and noninvasive assay of 
annexin-V-FITC is designed for early detection of apoptosis. 
PS, which is normally located on the inner surface of the 
plasma membrane, translocates to the outer surface of the 
plasma membrane after an induction of apoptosis, appar-
ently through an active mechanism.41 Annexin-V-FITC is 
a probe with a high affinity for PS, which has provided an 
easy method for the detection of apoptosis, since PS exposure 
is a widespread event during apoptosis, which occurs prior 
to membrane leakage and DNA-associated changes.42 As 
shown in Figure 4, the treatment of MCF-7 cells with the 
IC
50 
concentration of FALHE-induced translocation of PS to 
the outer membrane after 48 hours, while there was no sign 
of translocation in the control cells.
To confirm the microscopic detection of PS externaliza-
tion, we carried out the flow cytometric analysis using annex-
in-V-FITC and PI double staining. Treatment with FALHE 
for 24 hours significantly elevated the number of early 
(annexin-V positive; PI negative) and late (annexin positive; 
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Notes: The luminescence assay revealed an activation of caspase-9 after 12 hours and caspase-8 after 72 hours of treatment with Falhe. *P0.05.
Abbreviations: Falhe, Ferulago angulata leaves hexane extract; rlU, relative luminescence unit.
PI positive) apoptotic cells to 17.7% and 12.45%, respec-
tively (Figure 5B). These numbers reached to 20.5% and 
16.15% after 48 hours of treatment, respectively (Figure 5C). 
Meanwhile, the number of necrotic cells also significantly 
increased after 48 hours and 72 hours (Figure 5D), which 
was expected since due to the long incubation time with 
FALHE and its cytotoxic effects, some cells showed necrotic 
characterizations.43 The result of flow cytometric analysis 
confirmed the  induction of apoptosis by FALHE in a time-
dependent manner (Figure 5E). 
cell cycle arrest at g1 phase induced 
by Falhe
Previous studies44,45 have reported that the regulation of cell 
death and cell proliferation shares prevalent proteins and mol-
ecules in multicellular organisms. Indeed, cell cycle regula-
tion and apoptosis are regulated by several mutual genes.44 A 
direct correlation between apoptosis and cell cycle shows that 
apoptosis and mitosis have very close morphological charac-
teristics. During either of the processes, after the cells detach, 
they become rounded, condense their chromatin, and display 
membrane blebbing.45 In spite of some shared features, there 
are critical differences between mitosis and apoptosis.46 For 
example, cell membrane proteins are cross-linked during 
apoptosis, resulting in the rigidity of the membrane, and 
apoptotic cells are normally phagocytized by macrophages 
or adjacent cells. In contrast, during mitosis, the segregation 
of DNA and the division of the cell by cytokinesis leading to 
two healthy and viable daughter cells, are observed.47 To ana-
lyze the respective connection, we investigated the cell cycle 
progression in MCF-7 cells upon treatment with FALHE 
in a time-dependent pattern for 24, 48, and 72 hours. This 
experiment was carried out to determine the effect of FALHE 
on the DNA content of MCF-7 cells by cell cycle phase 
distribution (gap [G]
0
/G
1
, synthesis [S], and G
2
/mitosis [M]) 
(Figure 6). The results demonstrated that the FALHE signifi-
cantly arrested the cell cycle progression at the G
1
 phase in a 
time-dependent manner. The number of MCF-7 cells at this 
phase increased from 58.93% (untreated control) to 67.31% 
(72 hours). Meanwhile, the number of cells in the S and G
2
/M 
phases reduced after 72 hours of treatment compared to the 
control. Furthermore, the significant and time-dependent 
elevation in the cell population at sub-G
1
 phase presenting 
the hypodiploid DNA in MCF-7 cells elicited the number of 
cells undergoing apoptosis. 
caspase-8 and caspase-9 activation 
induced by Falhe
The caspase cascade signaling system is a critical factor in the 
process of apoptosis, which is precisely controlled by a vari-
ety of proapoptotic and antiapoptotic molecules.48 After treat-
ment of MCF-7 cells with IC
50
 concentration of FALHE for 3, 
6, 12, 24, 48, and 72 hours, caspase-8 and caspase-9 enzyme 
activity was evaluated. The activity of caspase-8 significantly 
increased at 72 hours, while caspase-9 activity significantly 
rose at 12, 24, 48, and 72 hours of treatment (Figure 7). 
The apoptosis-inducing potential of FALHE through the 
mitochondrial pathway was confirmed by the activation of 
caspase-9 after 12 hours. Furthermore, the elevated activ-
ity of caspase-8 after treatment with FALHE has thrown 
light on the possible contribution of extrinsic pathway to 
the induction of apoptosis by FALHE at the late stage of 
treatment. Involvement of more than a single apoptotic 
pathway in the induction of PCD by anticancer compounds 
is well-established, especially by plant-derived natural 
agents, such as curcumin.49,50 In this study, untreated cells 
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Figure 8 images of McF-7 cells.
Notes: These images of McF-7 cells (×20) were treated with Falhe at ic50 concentration, stained with different specific dyes, detecting total nuclear intensity, MMP, 
cytochrome c release, and cell membrane permeability. The images from each row were captured from the specific field of treated sample.
Abbreviations: Falhe, Ferulago angulata leaves hexane extract; ic50, half maximal inhibitory concentration; MMP, mitochondrial membrane potential.
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Figure 9 Quantitative analysis of multiparameter cytotoxicity assay revealed changes in total nuclear intensity, cell membrane permeability, MMP, and cytochrome c 
release. 
Notes: Following treatment with FALHE for 48 hours, significant elevation in total nuclear intensity, cell membrane permeability, cytochrome c release associated with 
reduction in MMP were detected. (*P0.05).
Abbreviations: MMP, mitochondrial membrane potential; Falhe, Ferulago angulata leaves hexane extract.
did not show any increase in the activity of caspase-8 and 
caspase-9; however, activity was significantly and time 
dependently elevated after treatment with FALHE. The role 
of caspase-9 has previously been determined to be a step 
prior to the  activation cascade of the mitochondrial pathway 
that results in apoptosis.51 Caspase-9 activation is heavily 
regulated by apoptosome, which converts procaspase-9 to 
caspase-9 by enzymatic cleavage.15
Multiparameter cytotoxicity analysis
To determine the possible mechanism of action for the 
induced apoptosis by FALHE, we investigated critical 
biochemical and morphological changes in MCF-7 cells, 
in specific nuclear condensation, and in mitochondrial-
initiated events. Hoechst 33342 staining demonstrated that 
numerous cells treated with FALHE displayed nuclear con-
densation shown with blue fluorescent intensity (Figure 8). 
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Figure 10 graph demonstrates the difference between treated and untreated cells. 
Notes: Human apoptosis proteome profiler array in MCF-7 cells treated with FALHE at IC50 concentration for 48 hours. *P0.05.
Abbreviations: sMac, second mitochondria-derived activator of caspases; XiaP, X-linked inhibitor of apoptosis protein; igFBP, insulin-like growth factor binding proteins; 
TnF, tumor necrosis factor; Trailr, TnF-related apoptosis-inducing ligand; ic50, half maximal inhibitory concentration.
Nuclear intensity (which directly corresponds to apoptotic 
chromatin changes), cell membrane permeability, MMP, and 
cytochrome c release were quantified (Figure 9). Nuclear 
intensity significantly increased after 48 hours of treatment 
with FALHE. A concurrent elevation in the cell membrane 
permeability shown with green fluorescent intensity was also 
exhibited for the same period (Figure 8). MMP was signifi-
cantly decreased in the MCF-7 cells treated with FALHE, 
as shown by a conspicuous attenuation in the red fluorescent 
intensity (Figure 8).
Furthermore, FALHE triggered a significant transloca-
tion of cytochrome c from mitochondria into cytosol. At 
48 hours, FALHE triggered approximately threefold cyto-
chrome c release represented by cyan fluorescent intensity 
in Figure 8. 
Apoptosis proteome profiler analysis
To further examine the detailed pathways responsible for 
induced apoptosis by FALHE toward MCF-7 cells, screening 
of critical proteins that are involved in various pathways of 
apoptosis was carried out. As shown in Figure 10, critical 
 proteins involved in the intrinsic pathway of apoptosis, includ-
ing Bad, Bax, cytochrome c, second  mitochondria-derived 
activator of caspases (SMAC)/DIABLO, and serine pro-
tease HtrA2/Omi were significantly overexpressed after 
48 hours of treatment, while the expression of antiapoptotic 
proteins of Bcl-2, sur vivin, X-linked inhibitor of apoptosis 
protein (XIAP) were downregulated. Additionally, p21 and 
p27, which are cell proliferation suppressor proteins, were 
upregulated. Different insulin-like growth factor binding 
proteins (IGFBPs) were also upregulated while treatments. 
Specific ligands of the tumor necrosis factor (TNF)-α 
involved in the extrinsic  pathway and death receptors, such as 
soluble TNF receptor (R) 2, TNF-related apoptosis-inducing 
ligand (TRAIL)R-3, and TRAILR-4 were slightly induced 
by treatment with FALHE.
The induced apoptosis by FALHE was associated with 
significant changes in the expression level of proteins from 
Bcl-2 family. We found out that the expression of the 
 antiapoptotic protein of Bcl-2 was significantly reduced, 
while proapoptotic proteins of the Bcl-2 family, including 
Bax and Bad, were significantly expressed after treatment 
with FALHE. Changes in the expression of the Bcl-2 family 
proteins led to the overexpression of cytochrome c, which 
resulted in the translocation of cytochrome c from the 
 mitochondria to the cytosol as proved by the multiparameter 
cytotoxicity assay.52 Besides cytochrome c, there are other 
proteins, such as SMAC/DIABLO and the serine protease 
HtrA2/Omi, that are released through the mitochondrial 
permeability transition pores provided by Bax protein in the 
inner mitochondrial membrane.53 
Cytochrome c release has a critical role in the activation 
of the intrinsic pathway of apoptosis as an important factor in 
the formation of the apoptosome, while SMAC/DIABLO and 
HtrA2/Omi suppress the activity of inhibitors of apoptosis 
proteins (IAPs), such as survivin and XIAP, whose expres-
sion was significantly reduced in our experiment.54 IGFBPs 
have been proved to significantly suppress the prolifera-
tion of different cell types. Previous studies have shown 
that IGFBPs are involved in the induction of apoptosis in 
MCF-7 cells via a death receptor-mediated pathway.55 The 
activation of apoptosis by a death receptor-mediated 
pathway was also suggested by the expression of TNF-α 
as the activator ligand for the death receptors,  including 
TNFR1 and TNFR2, which are involved in the extrinsic 
pathway.56 In addition, the activation of caspase-8 after 
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Notes: Quantitative analysis of gene expression in MCF-7 cells after 72 hours of treatment with FAHLE showed a significant elevation in the expression of Bax, p21, and 
p27 genes, compared to the control. Meanwhile, gene expression of Bcl-2 did not elicit significant changes. *P0.05.
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Figure 12 Immunofluorescence analysis.
Notes: An immunofluorescence analysis of (A) Bax and (B) Bcl-2 in MCF-7 cells depicted a marked elevation in the fluorescent intensity of Bax and reduction in the 
fluorescent intensity of Bcl-2 antibodies conjugated to FITC, in a time-dependent manner. (C) Quantitative analysis of Bax and Bcl-2 expression in McF-7 cells showed a time 
dependent increase in the Bax expression and decrease in the Bcl-2 expression at the protein level. *P0.05.
Abbreviation: FITC, fluorescein isothiocyanate.
72 hours of treatment with FALHE compared to the activa-
tion of caspase-9 after 12 hours of treatment, as shown in 
the luminescence analysis, suggests an activation of the 
intrinsic pathway followed by an  activation of the extrinsic 
pathway at the late stage of treatment. Additionally, the 
cell cycle has been shown to be involved in the suppression 
of cyclin-dependent kinases, which are responsible for the 
G
1
-to-S transition.57
Falhe upregulated the gene expression 
of Bax, p21, and p27
Since the protein array analysis showed the most significant 
changes in the expression of the Bcl-2, Bax, p21, and p27 pro-
teins, we investigated the expression of these proteins at the 
gene level, using the quantitative polymerase chain reaction 
analysis. The result showed a significant elevation in the gene 
expression of Bax, p21, and p27, which supported our findings 
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from the protein array analysis. However, Bcl-2 gene expres-
sion did not significantly change during 72 hours of treatment 
(Figure 11). These results suggest that FALHE treatment 
induces cell cycle arrest at the G
1
 phase via overexpression of 
p21 and p27 at the gene level. Recent studies on the p21 and 
p27 proteins have determined the critical role of these cell-cycle 
inhibitors on cell division and, subsequenltly, on cancer therapy 
approaches, since various cancer cells contain mutations in 
members of the proteins that regulate cyclin-dependent kinase 
activity.58,59 Therefore, apoptotsis-inducing agents with the 
ability to upregulate p21 and p27 proteins at the gene and pro-
tein level can be identified as promising anticancer agents. 
Falhe upregulated the protein 
expression of Bax and downregulated 
the protein expression of Bcl-2
Due to the important role of Bcl-2 and Bax proteins in the 
mitochondrial-dependent apoptosis, expression of these pro-
teins was investigated using immunofluorescence analysis. 
DAPI dye was used to stain the nucleus of the MCF-7 cells and 
in determining the number of cells. As shown in Figure 12, 
the number of MCF-7 cells decreased in a time-dependent 
manner in the treatment group as compared to the control 
group. The fluorescent intensity of the Bax-conjugated 
antibody was markedly increased after increasing the time 
of treatment with FAHLE (Figure 12A). In contrast, the fluo-
rescent intensity of Bcl-2 was conspicuously decreased in the 
same time period (Figure 12B). Quantitative analysis of the 
result showed a significant upregulation of Bax associated 
with significant downregulation of Bcl-2 after 24, 48, and 
72 hours of treatment (Figure 12C). The perturbation in the 
protein expression of Bcl-2 compared to its unchanged gene 
expression after 72 hours of treatment suggested that in spite 
of FALHE treatment, the Bcl-2 gene was still expressed and 
its activity was only significantly suppressed at the protein 
level. However, Bax expression was upregulated both at the 
gene and protein level.
Conclusion
In conclusion, the plant F. angulata has been found to have 
the potential of inducing mitochondrial-mediated apoptosis 
in MCF-7 cells through the activation of caspase enzymes. 
Figure 13 illustration of the possible molecular pathway for the induced apoptosis triggered by Falhe.
Abbreviations: Falhe, Ferulago angulata leaves hexane extract; iaP, inhibitors of apoptosis proteins; sMac, second mitochondria-derived activator of caspases; XiaP, 
X-linked inhibitor of apoptosis protein; M, mitosis; G, gap; S, synthesis; CDK, cyclin-dependent kinases; FITC, fluorescein isothiocyanate. 
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Furthermore, the active role of mitochondria in the induction 
of apoptosis was confirmed by the release of cytochrome c 
and reduction in MMP. The cell cycle arrest in G
1
 phase 
was proved to be one of the possible mechanisms for sup-
pressing cell proliferation, which suggests to be induced by 
the upregulation of p21 and p27 proteins. The suggested 
molecular pathway for the induced apoptosis is summarized 
in Figure 13. Our result demonstrated that F. angulata is a 
promising plant for cancer therapy. However, further in vitro 
and in vivo studies on the active compounds of this plant are 
still required.
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apoptotic effect of Ferulago angulata
Supplementary material
Table S1 serum biochemical analysis of rats
A
Animal  
groups
Kidney function test
Sodium  
(mM/L)
Potassium  
(mM/L)
Chloride  
(mM/L)
Co2  
(mM/L)
Anion gap  
(mM/L)
Urea  
(mM/L)
Creatinine 
(µM/L)
Vehicle 138.66±0.76 3.7±0.01 100.21±0.33 25.9±0.44 13.3±0.56 5.32±0.47 32.15±1.76
Falhe (2 g/kg) 142.21±0.51 4.1±0.3 101.24±0.4 27.78±0.98 15.5±0.64 6.13±0.54 30.21±1.27
Falhe (5 g/kg) 140.21±0.77 4.0±0.02 105.27±0.33 25.26±0.8 16.15±0.44 6.99±0.29 30.15±1.19
B
Animal  
groups
Liver function test
Total protein  
(g/L)
Albumin  
(g/L)
Globulin  
(g/L)
TB  
(µmol/L)
AP  
(U/L)
ALT  
(U/L)
AST  
(U/L)
GGT  
(U/L)
Vehicle 70.6±1.6 39.9±0.9 29.7±1.8 1.1±0.05 161.5±5.7 30.9±1.4 24.2±2.8 0.45±0.07
Falhe (2 g/kg) 67.9±1.8 38.5±0.3 30.6±1.2 1.4±0.06 163.8±4.1 35.5±1.7 25.48±2.9 0.57±0.09
Falhe (5 g/kg) 69.7±1.6 38.7±0.9 31.5±1.5 1.4±0.04 163.3±5.2 36.7±1.8 27.7±4.2 0.6±0.03
C
Animal  
Groups
Hematological test
HGB  
(g/dL)
HCT  
(%)
RBC  
(106 cells/µL)
MCV  
(fL)
MCH  
(pg)
MCHC  
(g/dL)
RDW  
(%)
WBC  
(103/µL)
Platelet  
(103/µL)
Vehicle 16.03±0.7 39±0.00 9.3±0.1 60.2±0.5 17.5±0.3 33.34±0.7 14.1±0.4 6.2±0.4 999.5±32.5
Falhe (2 g/kg) 16.27±0.9 39±0.00 9.4±0.2 61.4±0.6 16.9±0.6 33.01±0.5 12.23±0.1 6.0±0.3 975.3±35.2
Falhe (5 g/kg) 16.38±0.2 38±0.00 9.3±0.1 59.8±0.7 15.9±0.9 32.93±0.9 12.7±0.4 5.9±0.2 969.2±23.8
Notes: serum biochemical analysis of rats did not show any sign of Falhe toxicity on (A) renal function test, (B) liver function test, and (C) hematological parameters of 
the rodents, when compared with the control group. Values expressed as mean±standard deviation.
Abbreviations: alT, alanine aminotransferase; asT, aspartate aminotransferase; aP, alkaline phosphatase; ggT, g-glutamyl transferase; hcT, hematocrit; hgB, hemoglobin; 
Mch, mean corpuscular hemoglobin; Mchc, mean corpuscular hemoglobin concentration; McV, mean corpuscular volume; rBc, red cell count; rDW, red cell distribution 
width; TB, total bilirubin; WBc, white cell; Falhe, Ferulago angulata leaves hexane extract.
